Dr Michael Makanga designated as next EDCTP Executive Director
- Last Updated on Tuesday, 14 July 2015 13:27
Dr Michael Makanga is a clinician-scientist born and raised in Uganda with (after medical qualification) 24 years of professional experience of working on health and poverty related diseases in sub-Saharan Africa. This includes 20 years of work experience on medical product development and clinical regulatory activities. He holds a Medical Degree from Makerere University, Uganda, and has been in various clinical and research positions before and after undertaking an MSc at the University of Liverpool, and then a PhD at the Liverpool School of Tropical Medicine, United Kingdom.
He subsequently was the Head of the Clinical Trials Facility and Outpatient Clinic in the Kenya Medical Research Institute - Wellcome Trust Collaborative Centre, Kilifi, Kenya, which is part of the tropical collaboration programme of Liverpool and Oxford universities.
In 2004, Dr Makanga joined EDCTP where he held various management positions. He was appointed as Director of South-South Cooperation and Head of EDCTP Africa Office in Cape Town, South Africa, in 2008.
During his 11 years at EDCTP, Dr Makanga has built up significant experience in quality assurance, project management and evaluation, health and research management as well as diplomacy and engagement with health and regulatory authorities in sub-Saharan Africa and Europe.
|Dr Michael Makanga speaking at the meeting of African Ministers of Health in Addis Ababa, Ethiopia|
|Dr Michael Makanga welcomes Commissioner Carlos Moedas at Khayelitsha (Cape Town, South Africa), where EDCTP-funded research is conducted|
The second programme of EDCTP (2014-2024) supports all clinical trial phases (I-IV) including health services optimisation research. Research, health research ethics and regulatory capacity development remain part of the funding strategy in order to strengthen the conditions for conducting clinical research in sub-Saharan Africa.
The EDCTP programme will be executed through partnerships between European and African institutions and researchers in collaboration with the pharmaceutical industry and like-minded organisations globally.
The programme is implemented as part of the European Framework Programme for Research and Innovation, Horizon 2020, and governed by the African and European Participating States.